PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivity. Dominguez-Vigil IG, Banik K, Baro M, Contessa JN, et al. Mol Cancer Ther 2025 Apr 29. doi: 10.1158/1535-7163.MCT-24-0978.

Read + Share

Amedeo Smart

Independent Medical Education

Dominguez-Vigil IG, Banik K, Baro M, Contessa JN, et al. PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivity. Mol Cancer Ther 2025 Apr 29. doi: 10.1158/1535-7163.MCT-24-0978.
PMID: 40296663